Irina Sandulenko

Dr. Irina Sandulenko


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2021 in Processes
Verified
Journal Article
Open access
PDF file
Konstantin I. GalkinKonstantin I. Galkin
Konstantin I. Galkin
ISIrina Sandulenko
Irina Sandulenko
APAlexander Polezhaev
Alexander Polezhaev
This mini-review highlights the recent research trends in designing organic or organic-inorganic hybrid molecular, biomolecular and macromolecular systems employing intermolecular Diels–Alder cycloadditions of biobased, furan-containing substrates and maleimide dienophiles. The furan/maleimide Diels–Alder reaction is a well-known process that may proceed with high efficiency under non-catalytic and solvent-free conditions. Due to the simplicity, 100% atom economy and biobased nature of many furanic substrates, this type of [4+2]-cycloaddition may be recognized as a sustainable “click” approach with high potential for application in many fields, such as fine organic synthesis, bioorganic chemistry, material sciences and smart polymers development.

Verified
Journal Article
Open access
PDF file
Konstantin I. GalkinKonstantin I. Galkin
Konstantin I. Galkin
DZDaria Zakharova
Daria Zakharova
RARinat R. Aysin
Rinat R. Aysin
ADAnastasia A. Danshina
Anastasia A. Danshina
APAlexandra M. Pak
Alexandra M. Pak
KEKsenia S. Egorova
Ksenia S. Egorova
In the chemistry of bio-based furans, the Diels–Alder reaction plays an important role as a renewable route for the synthesis of fuels, fine chemicals, and monomers. Nonetheless, the unfavorable kinetic and thermodynamic parameters inherent to the Diels–Alder reaction involving furans as dienes often lead to the reversibility of cycloaddition, resulting in decreased equilibrium conversion and diastereoselectivity. In this study, we present a new strategy for overcoming the problem of reversibility in chemical reactions. We demonstrate that conducting the reaction under solvent-free conditions can facilitate the transition from a molten state formed by the initial reactants to a solid phase containing the reaction product along with an excess of the initial substrate. According to our results, such a liquid-to-solid transition of the reaction mixture can lead to exceptionally high conversion and diastereoselectivity in the furan–maleimide Diels–Alder reaction, particularly for challenging electron-poor furanic substrates. Our approach enables the reversible furan–maleimide Diels–Alder reaction to be performed in a cleaner and more environmentally friendly manner, free from the complexities associated with the use of solvents and the need for purification from side products.

1 December 2022 in Russian Chemical Bulletin
Verified
Journal Article
Closed access
PDF file
ISIrina Sandulenko
Irina Sandulenko
MZM. V. Zelentsova
M. V. Zelentsova
ATA. A. Tyutyunov
A. A. Tyutyunov
SMS. K. Moiseev
S. K. Moiseev

28 December 2024 in INEOS OPEN
Verified
Journal Article
Open access
ISIrina Sandulenko
Irina Sandulenko
MZM. B. Zelentsova
M. B. Zelentsova
ASA. F. Smol'YAkov
A. F. Smol'YAkov
AAA. A. Ambarsumyan
A. A. Ambarsumyan
SMS. K. Moiseev
S. K. Moiseev
A C(7)-fluorinated derivative of oxycodone was obtained for the first time by the electrophilic fluorination of the lithium enolate of oxycodone. The reaction involving Selectfluor proceeds stereoselectively and results in the formation of a single C(7)-epimer. The structure of the newly prepared 7α-fluorooxycodone was confirmed by X-ray diffraction.

24 May 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Konstantin I. GalkinKonstantin I. Galkin
Konstantin I. Galkin
ISIrina Sandulenko
Irina Sandulenko
This perspective highlights current trends and recent advances in the introduction of fluorine and fluoroalkyl moieties into the furanic core of biobased furfural-derived furans. Existing and potential applications of these fluorinated building blocks in the development of pharmaceuticals and advanced materials are also discussed.